Literature DB >> 26985303

Glutaminase GLS1 Inhibitors as Potential Cancer Treatment.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2016        PMID： 26985303      PMCID： PMC4789657          DOI： 10.1021/acsmedchemlett.6b00016

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Glutamine addiction: a new therapeutic target in cancer.

Authors:  David R Wise; Craig B Thompson
Journal:  Trends Biochem Sci       Date:  2010-08       Impact factor: 13.807

2.  Cancer metabolism: is glutamine sweeter than glucose?

Authors:  Weiqin Lu; Helene Pelicano; Peng Huang
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

Review 3.  Therapeutic strategies impacting cancer cell glutamine metabolism.

Authors:  Michael J Lukey; Kristin F Wilson; Richard A Cerione
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808
  3 in total
  3 in total

Review 1.  Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer.

Authors:  Nicholas S Akins; Tanner C Nielson; Hoang V Le
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

Review 2.  MicroRNAs and Metabolism: Revisiting the Warburg Effect with Emphasis on Epigenetic Background and Clinical Applications.

Authors:  Zsuzsanna Gaál
Journal:  Biomolecules       Date:  2021-10-17

Review 3.  Metabolic Plasticity in Chemotherapy Resistance.

Authors:  Maria Andrea Desbats; Isabella Giacomini; Tommaso Prayer-Galetti; Monica Montopoli
Journal:  Front Oncol       Date:  2020-03-06       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.